Free Trial
OTCMKTS:SNPHY

Santen Pharmaceutical (SNPHY) Stock Price, News & Analysis

$10.41 +0.39 (+3.84%)
As of 12:41 PM Eastern

About Santen Pharmaceutical Stock (OTCMKTS:SNPHY)

Key Stats

Today's Range
$10.03
$10.41
50-Day Range
$10.03
$11.85
52-Week Range
$8.65
$13.00
Volume
788 shs
Average Volume
7,238 shs
Market Capitalization
N/A
P/E Ratio
0.10
Dividend Yield
463.96%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Santen Pharmaceutical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

SNPHY MarketRank™: 

Santen Pharmaceutical scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Santen Pharmaceutical.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Santen Pharmaceutical is 0.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.04.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Santen Pharmaceutical is 0.10, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.86.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Santen Pharmaceutical has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Santen Pharmaceutical has recently decreased by 29.63%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Santen Pharmaceutical pays a meaningful dividend of 1.47%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Santen Pharmaceutical does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Santen Pharmaceutical is 46.34%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Santen Pharmaceutical's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Santen Pharmaceutical has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Santen Pharmaceutical has recently decreased by 29.63%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Santen Pharmaceutical this week, compared to 0 articles on an average week.
Receive SNPHY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Santen Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

SNPHY Stock News Headlines

Santen Pharmaceutical Co (SNPHY) - Investing.com UK
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Santen Pharmaceutical FY Net Y36.26B Vs Net Y26.64B
Santen Pharmaceutical Announces Share Buyback Plan
See More Headlines

SNPHY Stock Analysis - Frequently Asked Questions

Santen Pharmaceutical's stock was trading at $10.12 at the start of the year. Since then, SNPHY stock has increased by 2.9% and is now trading at $10.41.

Shares of SNPHY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
Current Symbol
OTCMKTS:SNPHY
CIK
1501108
Fax
N/A
Employees
4,144
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
0.10
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:SNPHY) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners